Infectious diseases

Sessions

Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour

Infectious diseases — E-health

Infectious diseases — Harm reduction

Infectious diseases — Monitoring

Infectious diseases — New trends

Opiates

Infectious diseases — Opiates

Infectious diseases — Programme evaluation

Infectious diseases — Vulnerable groups

13:20

Treatment — challenges, determinants and responses

13:20 to 14:50

Networking zone 3 (N3)

Dominique Lopez

The future of hepatitis C among people who inject drugs

13:20 to 14:50

Main stage

Dagmar HedrichErika Duffell

Improving delivery of healthcare programmes

13:20 to 14:50

Central square 3 (C3)

Graça Vilar

Risk behaviours in context

13:20 to 14:50

Networking zone 2 (N2)

Anja Busse

Injecting, risk and reducing harm

13:20 to 14:50

Networking zone 3 (N3)

Thomas Néfau

Evidence to guide future practice and policy

Enhancing hepatitis C treatment outcomes among people who use drugs

13:20 to 14:50

Insights zone 1 (I1)

Catharina MatheïAdrian Dunlop

15:00

Practical tools developed under the EMCDDA ‘Harm reduction initiative’

Enhancing the role of drug treatment services for HCV elimination among people who inject drugs

15:00 to 16:30

Central square 1 (C1)

Dagmar HedrichMatthew Hickman

Epidemiology of hepatitis C among people who use drugs — Data to inform future planning

15:00 to 16:30

Insights zone 3 (I3)

Vana SypsaJack Stone

16:50

Closing the gaps: HIV and Hepatitis continuum of care with a focus on people who inject drugs

16:50 to 18:20

Central square 1 (C1)

Viktor Mravčík

Striving towards the future elimination of Hep C among people who use drugs

16:50 to 18:20

Futures zone 1 (F1)

Eberhard SchatzPerrine Roux

18:30

Developing new prevention strategies to improve the situation of clients and employees of harm reduction services

18:30 to 19:30

Networking zone 2 (N2)

Gabi Becker

Challenges for harm reduction II

18:30 to 19:30

Insights zone 3 (I3)

Alessandro Pirona

10:45

Epidemiology of infectious diseases

10:45 to 12:15

Insights zone 4 (I4)

Thomas Seyler

Opioid-related deaths: learning from epidemiological studies

10:45 to 12:15

Insights zone 3 (I3)

Sarah Welch

Presentations

Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour

Wednesday, 23 October

13:20

Oral presentation

The epidemiology of drug use and hepatitis C — Where are we now?

13:30

Treating drug abuse and health issues in the criminal justice system. An empirical research on the linkage of health and criminal justice interventions, France

13:30 to 13:40

Networking zone 3 (N3)

Ivana Obradovic

Short communication

Perceptions on social determinants of opioid dependence recovery

13:30 to 13:40

Networking zone 3 (N3)

Leonor Brito

Oral presentation

Substance Use Sex Index (SUSI): towards a new behaviour change assessment tool

13:30 to 13:45

Networking zone 2 (N2)

Nadine Ezard

Oral presentation

Balancing welfare and market institutional logics. Procurement regulations for social services, such as addiction treatment, in four Nordic welfare countries

13:30 to 13:45

Central square 3 (C3)

Kerstin Stenius

13:35

Oral presentation

What future strategies will enhance integration of care for drug use and hepatitis C?

13:40

Reverse transition from injecting to smoking heroin and/or crack cocaine on lower methadone dose: sub-therapeutic dosing or safer drug use?

13:40 to 13:50

Networking zone 3 (N3)

Felicia Heidebrecht

13:45

Oral presentation

Chemsex experiences: pleasures, harms and care

13:45 to 14:00

Networking zone 2 (N2)

Maitena Milhet

Oral presentation

Can liaison and diversion services increase referral to drug and alcohol treatment?

13:45 to 14:00

Central square 3 (C3)

Kate Morley

13:50

Short communication

Benzodiazepine management in primary care: barriers and facilitators

13:50 to 14:00

Networking zone 3 (N3)

Kristien Coteur

Oral presentation

How can modelling inform future interventions to integrate hepatitis C care and drug user health?

14:00

The counselors’ perspective on the use of methamphetamine in a sexual context among men who have sex with men

14:00 to 14:15

Networking zone 2 (N2)

Valérie Aubut

Oral presentation

Treatment in therapeutic communities: the experience of Lisbon and Tagus Valley Region

14:00 to 14:15

Central square 3 (C3)

Elizabete Pereira

Short communication

Referral of European and third country non-national clients in Belgian drug treatment

14:00 to 14:15

Networking zone 3 (N3)

Eva Blomme

14:05

Oral presentation

What is the future role of policy makers to facilitate better integration of hepatitis C and drug user health?

14:05 to 14:20

Main stage

Ricardo Baptista Leite

14:10

Short communication

HIV and drug abuse: relationship and treatment challenges

14:10 to 14:20

Networking zone 3 (N3)

Sara Dehanov

14:15

Oral presentation

Faster, higher, stronger? Results from a Belgian survey on PED use among gym-goers

14:15 to 14:30

Networking zone 2 (N2)

Bertrand Fincoeur

Oral presentation

The influence of institutional response on the individual's recovery from drug misuse

14:15 to 14:30

Central square 3 (C3)

Carolina Cunha

14:20

Short communication

Motivation for treatment predict adherence to treatment in a randomised clinical trial

14:20 to 14:30

Networking zone 3 (N3)

Zhanna Gaulen

Oral presentation

What is required for better integration of hepatitis C and drug user health in the future: a community perspective?

14:30

Psychiatric assessment of prisoners in opioid-maintenance treatment: emphasis on ADHD

14:30 to 14:40

Networking zone 3 (N3)

Marisa Silbernagl

14:35

INHSU Connecting with Care Video: Meaningful involvement of people with lived experience in HCV care delivery

14:35 to 14:40

Main stage

14:40